22 March 2024
News&Media
26 January 2024
Dichbio and DIESSE announce strategic partnership for the distribution of ESR solutions in China
13 September 2023
DIESSE Biotech Campus - Inauguration today of the most advanced Italy based and European excellence IVD biotechnology centre
8 March 2023
DIESSE announces strategic collaboration with SAIHUB for creating a Data Platform essential for the implementation of artificial intelligence in diagnostic systems
22 December 2022
aeChem grants DIESSE the exclusive access to its international patent that unlocks an innovative detection method on CHORUS immunoassay platforms
25 October 2022
DIESSE announces the launch of new kits for the quantification of Vitamine B12 and Folate on CHORUS system
26 September 2022
DIESSE Diagnostica Senese announces the publication of its first Sustainability Report
1 August 2022
DIESSE announces a strategic partnership with Grifols to distribute tests for biological drug monitoring in Italy
26 July 2022
DIESSE and Menarini Silicon Biosystems Inc. announced strategic partnership to distribute CHORUS TRIO in North America
20 July 2022
DIESSE Diagnostica Senese announces the approval by the Shareholders' Meeting of the transformation into a Benefit Company
21 June 2022
DIESSE makes a collection of E-BIKES available for employee use in order to encourage well-being
9 May 2022
DIESSE a supporto del progetto Pharma and Device Valley è felice dell’avvio della costruzione della piattaforma logistica toscana per le scienze della vita
17 February 2022
ViroGates announces the CE-IVD accreditation of suPARnostic® ELISA on the CHORUS Trio platform marketed by Italy-based DIESSE
6 December 2021
DIESSE and ViroGates announces a development, supply and collaboration agreement for adaption of suPARnostic® ELISA on the Chorus Trio platform
24 September 2021
Test rapidi per la misurazione degli anticorpi Covid-19 a disposizione dei lavoratori del comparto scuola comunale di Siena, in collaborazione con DIESSE e Asp Città di Siena.
23 June 2021
DIESSE announces a partnership with Grifols to develop tests for bioligic drugs monitoring
19 June 2021
REBuilding The Future. Evento di posa della prima pietra del DIESSE BIOTECH CAMPUS
9 March 2021
COVID-19: the alliance between Diesse and TLS produces the diagnostic kit used in clinical trials on monoclonal antibody therapy
19 February 2021
Diesse and AchilleS Vaccines working together for new monoclonal antibody based therapies
29 January 2021
DIESSE LAUNCHES THE SARS-CoV-2 “NEUTRALIZING” Ab, AN IMPORTANT TEST FOR MEASURING VACCINE EFFECTIVENESS
10 December 2020
DIESSE ANNOUNCES THE FIRST SARS-CoV-2 NEUTRALIZING ANTIBODIES RESEARCH KIT, USEFUL FOR MEASURING THE EFFECTIVENESS OF VACCINES
19 November 2020
DIESSE ANNOUNCES A NEW SARS-CoV-2 ANTIGEN TEST
3 November 2020
DIESSE ANNOUNCES THE NEW CONFIGURATION OF ITS CHORUS TRIO IMMUNOMETRIC ASSAY SYSTEM
15 October 2020
DIESSE ANNOUNCES ITS ENTRY INTO VETERINARY MEDICINE WITH THE FIRST INSTRUMENT FOR MEASURING ESR IN ANIMALS
8 October 2020
DIESSE ANNOUNCES A NEW KIT FOR THE DIAGNOSIS OF INFECTION FROM SARS-CoV-2 ON THE CHORUS SYSTEM
31 July 2020
COVID19 Diagnosis: Toscana Life Sciences and Diesse Diagnostica Senese announce strategic alliance for the development of a new kit
30 June 2020
DIESSE CELEBRATES 40TH ANNIVERSARY AND ANNOUNCES NEW VES-MATIC 5 INSTRUMENT
15 June 2020
DIESSE AUTOMATES THE SARS-CoV-2 KIT IN SINGLE-TEST FORMAT ON THE CHORUS INSTRUMENT
24 April 2020
DIESSE READY TO SUPPLY COVID-19 SERIOLOGICAL TESTS
18 March 2020
COVID-19: Spallanzani Institute and Diesse Diagnostica Senese announce an agreement for the development of serological tests.
18 March 2020